Indirect regulation of CYP2C19 gene expression via DNA methylation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2018-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/00498254.2017.1372648PMID 28840784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene expression

  2019cited by this paper
• Methylation of the Constitutive Androstane Receptor Is Involved in the Suppression of CYP2C19 in Hepatitis B Virus–Associated Hepatocellular Carcinoma

  2016influential reference
• High CYP2C19 phenotypic variability in gastrointestinal cancer patients

  2015influential reference
• CYP2C19 genotype–phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity

  2014cited by this paper
• Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro

  2013cited by this paper
• Regulatory polymorphisms in CYP2C19 affecting hepatic expression

  2013cited by this paper
• Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters

  2013cited by this paper
• Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19

  2012influential reference
• Gene Expression Profiling of Systems Involved in the Metabolism and the Disposition of Xenobiotics: Comparison between Human Intestinal Biopsy Samples and Colon Cell Lines

  2012cited by this paper
• Functions of DNA methylation: islands, start sites, gene bodies and beyond

  2012cited by this paper
• DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing

  2011cited by this paper
• Extrahepatic Cancer Suppresses Nuclear Receptor–Regulated Drug Metabolism

  2011cited by this paper
• Expression of Wild-Type and Variant Estrogen Receptor Alpha in Liver Carcinogenesis and Tumor Progression

  2011cited by this paper
• Functional Evaluation of Genetic and Environmental Regulators of P450 mRNA Levels

  2011cited by this paper
• Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients.

  2011cited by this paper
• The transcription factor GATA-4 regulates cytochrome P4502C19 gene expression.

  2010influential reference
• A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues

  2010cited by this paper
• Hepatocyte Nuclear Factor 4α Regulates Rifampicin-Mediated Induction of CYP2C Genes in Primary Cultures of Human Hepatocytes

  2010cited by this paper
• Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism

  2010influential reference
• Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.

  2010cited by this paper
• The transcriptional regulation of the human CYP2C genes.

  2009cited by this paper
• Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers.

  2008cited by this paper
• CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype

  2008influential reference
• Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes

  2007cited by this paper
• Effect of omeprazole and cimetidine on plasma diazepam levels

  2007cited by this paper
• Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver

  2007cited by this paper
• Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

  2007cited by this paper
• Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation

  2006influential reference
• Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers

  2006cited by this paper
• INVOLVEMENT OF HEPATOCYTE NUCLEAR FACTOR 4α IN THE DIFFERENT EXPRESSION LEVEL BETWEEN CYP2C9 AND CYP2C19 IN THE HUMAN LIVER

  2006cited by this paper
• Role of hepatocyte nuclear factor 3γ in the expression of human CYP2C genes

  2004cited by this paper
• Liver-Enriched Transcription Factors in Liver Function and Development. Part II: the C/EBPs and D Site-Binding Protein in Cell Cycle Control, Carcinogenesis, Circadian Gene Regulation, Liver Regeneration, Apoptosis, and Liver-Specific Gene Regulation

  2004cited by this paper
• Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes.

  2004cited by this paper
• Differential expression and function of CYP2C isoforms in human intestine and liver.

  2003cited by this paper
• Transcription

  2003influential reference
• Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter.

  2003cited by this paper
• Inhibition of cytochromes P450 by antifungal imidazole derivatives.

  2002cited by this paper
• Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells

  2002cited by this paper
• Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

  2001cited by this paper
• Metabolic characterization of the major human small intestinal cytochrome p450s.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Induction of CYP2C genes in human hepatocytes in primary culture.

  2001cited by this paper
• EMBOSS: the European Molecular Biology Open Software Suite.

  2000influential reference
• A discordance of the cytochrome P450 2C19 genotype and phenotype in patients with advanced cancer.

  2000influential reference
• The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene*

  1999cited by this paper
• Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19

  1999cited by this paper
• Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism.

  1999cited by this paper
• Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells.

  1998cited by this paper
• SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

  1998cited by this paper
• An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.

  1998cited by this paper
• The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene

  1998cited by this paper
• Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

  1998cited by this paper
• Artemisinin induces omeprazole metabolism in human beings

  1998cited by this paper
• Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells

  1998cited by this paper
• The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

  1998cited by this paper
• Fluvoxamine inhibits the CYP2C19‐catalyzed bioactivation of chloroguanide

  1997cited by this paper
• Effects of omeprazole and cimetidine on the urinary metabolic ratio of proguanil in healthy volunteers

  1996cited by this paper
• Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.

  1996cited by this paper
• Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study *

  1995cited by this paper
• A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements

  1994cited by this paper
• Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.

  1993cited by this paper
• Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.

  1991cited by this paper
• Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin.

  1990cited by this paper
• Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine.

  1989cited by this paper
• Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes.

  1987cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper
• Supporting Information Supporting Figure S2: Schematic Describing Stamp Signal Calculation and Dme Identification. (methods and Results: Genome-wide Identification of Densely Methylated Elements)

  year unknowncited by this paper

• Epigenetics in pharmacogenes encoding metabolizing enzymes of second-generation antipsychotics used in schizophrenia and its clinical implications

  2025cites this paper
• CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis

  2025cites this paper
• CYP2C19 genotype-phenotype correlation: current insights and unanswered questions

  2024cites this paper
• The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention

  2023cites this paper
• Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)

  2021cites this paper
• Clinical Implications of Epigenetic Regulation in Pharmacogenes Encoding Metabolic Enzymes for Second-Generation Antipsychotics in Schizophrenia

  2021cites this paper
• Cytochrome P450: genotype to phenotype

  2019cites this paper
• Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics

  2019cites this paper
• The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma

  2018cites this paper
• A new perspective on variation of voriconazole steady-state valley concentration in Chinese population: CYP2C19 DNA methylation

  year unknowninfluential citation